drug use patterns among participants in a woman-focused rct in georgia
DESCRIPTION
The purpose of this poster presentation is to depict preliminary results from small-scale RCT IMEDI study and show the drug use patterns among women who use illicit substance and the rate of HIV infection.TRANSCRIPT
Table # 1 Respondent’s Education
Table #6 Urine screening results for Amphetamines
Figure 1. Participant Flow Chart Table #2. Respondent’s Age Table #3 HIV/HCV prevalence Table #4. Respondents' marital Status
Results of urine screening revealed that illicit substance use declined over time
irrespective of condition (p<.001), please see table #5 and 6. Table #5 Urine screening results for Morphine
It is of great public health importance in Georgia to avoid the HIV and HCV rates that are seen in Georgia’s largest neighbor, Russia, where 30% of PWUD are HIV-positive (6), and up to 95% of PWUD are HCV-positive (7).
Women comprise only 2% of the patient population in substance use treatment in Georgia, and research-examining patterns of substance use in Georgian women is lacking.
1. Wechsberg WM, Krupitsky E, Romanova T, Zvartau E, Luseno W, Browne F, Middlesteadt Ellerson R, Zule W. Double jeopardy for drug using women in Russia: Injecting and sexual risk reported in a small trial. In: College on Problems of Drug Dependence Annual Meeting, June 20-25, 2009; Reno, NV.
2. Greig A, Peacock D, Jewkes R, Msimang S. Gender and AIDS: Time to act. AIDS 2008;22:S35-S43.
3. Georgian Research Institute of Addiction, New Way. Evaluation of drug treatment in Georgia. Tbilisi, Georgia: Georgian Research Institute of Addiction; 2008.
4. Stvilia K, Tsertsvadze T, Sharvadze L, Aladashvili M, del Rio C, Kuniholm MH, Nelson KE. Prevalence of hepatitis C, HIV, and risk behaviors for blood-borne infections: A population-based survey of the adult population of T’bilisi, Republic of Georgia. Journal of Urban Health 2006;83(2):289–298.
5. Bidzinashvili K, Kirtadze I. Report on the female IDU project. Tbilisi, Georgia: Step to Future; 2009.
6. Kruse GR, Barbour R, Heimer R, Shaboltas AV, Toussova OV, Hoffman IF, Kozlov AP. Drug choice, spatial distribution, HIV risk, and HIV prevalence among injection drug users in St. Petersburg, Russia. Harm Reduction Journal 2009;6:22.
7. Paintsil E, Verevochkin SV, Dukhovlinova E, Niccolai L, Barbour R, White E, Toussova OV, Alexander L, Kozlov AP, Heimer R. Hepatitis C virus infection among drug injectors in St Petersburg, Russia: Social and molecular epidemiology of an endemic infection. Addiction 2009.
Drug use patterns among participants in a woman-focused RCT in Georgia I. Kirtadze1,, D. O0ashvili1, K. O’Grady2, W. Zule3, E. Krupitsky4, W. Wechsberg3 H. Jones5,6
1 – Addic(on Research Center, Alterna(ve Georgia, Tbilisi 0177 Georgia (Republic of); 2 -‐Department of Psychology, University of Maryland, College Park, MD 20742, USA; 3 -‐ RTI Interna(onal, Research Triangle Park, NC 27709, USA; 4 -‐Department of Addic(ons, Bekhterev Research Psychoneurological Ins(tute, St. Petersburg 192019, Russia; 5–
UNC Horizons Program, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514, USA; 6 – Departments of Psychiatry and Obstetrics and Gynecology, School of Medicine, Johns Hopkins University, Bal(more, MD 21224, USA
This research was supported by NIDA grant R01 DA029880 (Hendrée E. Jones, PI). The authors would like to thank project IMEDI research staff who participated in data collection and study participants for their valuable time and effort. NIDA played no role in the: 1) study design; 2) collection, analysis, and interpretation of data; 3) writing of the report; or 4) decision to submit or where to submit the paper for publication. Authors declare no conflict of interest related to this study.
References
Background Results (continued) Results (continued)
Eligibility criteria: Injection of illicit drugs in the past 30 days verified by venipuncture stigmata and sexually active at least once in the past 30 days.
Intervention condition received a structured 12-session intervention focusing on HIV/HCV prevention, mental and physical health, drug and alcohol use cessation.
Usual care condition received information and case management for 12 sessions.
Urine drug screening was conducted at every session, baseline and 1- and 3-month follow up assessments.
Methods
Preliminary findings suggest treatment resulted in a marked reduction in use of illicit substances in both conditions. There were no significant differences in outcomes between the conditions. Interventions that are women-centered, accessible, confidential, receptive, and provide a non-judgmental and caring environment are beneficial for women with substance-use-related problems.
Conclusions The purpose of this poster presentation is to depict preliminary results from small-scale RCT IMEDI study and show the drug use patterns among women who use illicit substance and the rate of HIV infection.
Purpose
Screened for eligibility (n=172)
Included (n=128) met study inclusion criteria's
Interven(on group (n=64)
Usual Care group (n=64)
Excluded (n=44) did not met study criteria’s
-‐ 21 were not regular injectors -‐ 4 did not have sex during past 3 months -‐ 11 were not regular injectors and did not have regular sexual contacts during past 3 months -‐ 4 were non-‐injec(on drug users -‐ 4 faked urine samples
Results
Contact Information: Irma Kirtadze, M.D., Ph.D.(c) Senior Researcher
Acknowledgment
Addiction Research Center, Alternative Georgia 14a Nutsubidze Str., Office 2, 0177 Tbilisi, Georgia Email: [email protected]